Main > A1. CORP. INDEX. A-Am No. 1 > Allergan Inc./P C2

---

This data is not available for free

Allergan Inc./P C2's subsections
2008. 08.27.2008. Asterand
2009. 06.18.2009. Eye>Macular Edema
2009. 07.23.2009. Eye>Cataract
2009. 09.25.2009. Uro>OAB
2009. 10.23.2009. Eye>HyperTension
2010. 02.01.2010. Medical Aesthetic
2010. 02.04.2010. Corp. Acq.
2010. 03.03.2010. BMS
2010. 03.03.2010. Neuro.>Botulinum
2010. 03.09.2010. Neuro.>Upper Limb
2010. 04.01.2010. Serenity Pharma.
2010. 05.19.2010. Eye>Conjunctiviti
2010. 08.31.2010. Eye>HyperTension
2010. 09.24.2010. Eye>Uveitis
2010. 10.15.2010. Neuro.>Migraine O
2010. 11.25.2010. Eye>Dry Eye Dis.
2011. 02.16. Obesity
2011. 05.04. Mol. Partners AG
2012. 08.21. Molecular Partner
2012. 09.04. NJ R&D Center
2012. 11.16. Bus.. Acq.
2013. 01.18. Uro.>OAB
2013. 01.22. Acq. MAP Pharma.
2013. 02.20. Breast Implants
2013. 04.16. Neuro.>Migraine D
2013. 05.02. Dermal Filler
2013. 09.11. Eye>Crow s Feet Lines
2013. 09.25. MedyTox Inc.
2014. 04.22. Poison-Pill Defense
2014. 06.10. Rejects Valeant Offer
2014. 06.30. Ophthalmo.>DME
2014. 08.13. Uro.>IC/BPS
2014. 08.18. CFO
Allergan Cosmetics C2
Allergan Medical C2
Patents
R&D>Collaborations C2
Web-Site
Z - OK

Allergan Inc./P C2's products
This section has no products